Genie has transformed how Databricks users work with data, with 3x the accuracy of generic agents. We're sharing some of the research behind it and what makes building data agents challenging. Super proud of our research team's impact with this! https://t.co/eLB2ElVo8S
Taylor Swift is in the bay - Swiftie Clara!!🎉
We built this bot for all Swifties🤩🌈
Ask questions about her 👉 https://t.co/l2Uz8ypbPR
How to build this bot? check our Colab 👉 https://t.co/LAVEO9jsYI
#TaylorSwift#ErasTour#SwiftieClara#Swifties#LLM
Excited to announce @LaminiAI’s new public alpha: free, fast & furious LLM finetuning!
Finetuning was complex & expensive before. Now, anyone can do it in:
⏳10 mins
🧑💻3-5 lines of code
💸$0 free
👉🏻https://t.co/BfcMfWhoTx
🧸Free tier: toy ~400M LLMs. This is just the start 🧵
I’m super excited to announce @LaminiAI, the LLM engine that gives every developer the superpowers that took the world from GPT-3 to ChatGPT! We make it easy to rapidly train custom LLMs from @OpenAI @EleutherAI @Cerebras@Databricks@HuggingFace@Meta https://t.co/qUKQWNuzjQ 🧵
Overheard at an AI event...
audience: how do I build anything defensible on LLMs?
speakers: *crickets*
audience: *laughs*
The actual answer is just to ~build your own LLM~.
Buuuut this chart show what that's like right now. Don't forget your error handler ;)
What'll be that magical row that'll solve all our problems? Will unveil more of what I'm building soon!
@SouthwestAir Cancelled our flight from PDX to SJC and rebooked one for the next day. Currently stranded in Portland. Is Southwest able to help us find accommodation tonight and provide a hotel voucher?
For those of you not able to hear my talk at AAIC, here is a great write-up of the simufilam data on Seeking Alpha. With all the caveats of an open-label study,
$SAVA
#ENDAlz
https://t.co/LzwL6z0yX1
On Thursday, July 29th, at approximately 11 am ET, simufilam will be featured in a live podium presentation at AAIC
Watch and Listen Live to :
Lindsay H. Burns PhD - Sr. VP, Neuroscience
Share encouraging 9month Simufilam data
$SAVA #AAIC2021
Cassava Sciences Announces Positive Data with SavaDx from a Randomized Controlled Phase 2b Study of Simufilam
$SAVA #AAIC2021#ENDALZ
https://t.co/Rhc7x6Dr9u
Looking forward for you to Tune in next week for our Podium Presentation.
The Alzheimer’s Association International Conference (AAIC) is the largest and most influential international meeting dedicated to advancing dementia science.
@alzassociation $SAVA #ENDALZ I
Tune in @alzassociation
- On Monday, July 26th, New Clinical Data for SavaDx to be Shared in
a Poster Presentation
- On Thursday, July 29th, New Clinical Data for Simufilam to be Featured in a Podium Presentation
$SAVA
#AAIC#ENDALZ
Looking forward seeing you at #AAIC21 !
$SAVA @alzassociation
-On Monday, July 26th, New Clinical Data for SavaDx to be Shared in
a Poster presentation
- On Thursday, July 29th, Encouraging new Clinical Data for Simufilam to be Featured in a Podium Presentation
“We are honored AAIC’s scientific committee has invited us to present the latest clinical dataset for simufilam in an oral presentation on Thursday, July 29th.”
@alzassociation $SAVA #ENDALZ